TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Matthew Jowett, PhD Senior Health Financing Specialist Dept. Health Systems.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

1 Policy options to address access to chronic disease medicines Dr. Richard Laing Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical.
David B Evans, Director Health Systems Governance & Financing Progressive Pathways to Universal Health Coverage.
Understanding Mail Order Community pharmacists provide a valuable service desired by patients. Very rarely are mail order and community pharmacies allowed.
Progress and Strategy to achieve universal coverage in Lao PDR: Issues for discussion Presented at 4 th Technical review meeting for Health Policy and.
HOW THE NON-STATE SECTOR ENGAGE TO STEWARDSHIP OF MIXED SYSTEM IN IN VIETNAM Health Strategy and Policy Institute - Vietnam.
World Health Organization
1 Improving the Tax Treatment of Health Insurance Katherine Baicker Professor of Health Economics Harvard School of Public Health.
Shaping UHC Policy for Post 2015: Opportunities & Risks Jeanette Vega MD, DrPH Managing Director of Health NHIS 10 Anniversary Conference Accra, November.
1 Rising Health Care Costs: Can we Move Towards Higher-Value Care? Katherine Baicker Professor of Health Economics Harvard School of Public Health.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
WHO Regional Office for Europe HIV/TB Stakeholder Meeting Dr Hans Kluge Director Health Systems and Public Health Special Representative of the Regional.
Delmar Learning Copyright © 2003 Delmar Learning, a Thomson Learning company Chapter 6 Health Care Economics.
Government and Health Care Roughly 15 cents of every dollar spent in US is on health care US health care spending equaled $5841 per person in 2002 Governments.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
PAHO/WHO Seminar Brasilia October 2002 PAHO/WHO INTERNATIONAL SEMINAR ON CHALLENGES FOR COMPREHENSIVE PHARMACEUTICAL SERVICES BRASILIA, OCTOBER 2002 Experience.
Financing Systems Part 2 Social and Private Insurance Unit 7.
International Health Care Systems Kao-Ping Chua Jack Rutledge Fellow, American Medical Student Association.
Healthcare Reform in China and Its Impact on the Pharmaceutical Industry Hengpeng Zhu Institute of Economics Chinese Academy of Social Sciences
 You pay a premium into an insurance pool. In the event that you are sick or injured, the insurance policy pays all or part of your medical expenses.
1 Reimbursing Health Care Providers It is all about striking the right balance between economic incentives for over-treatment and under- treatment Yaseen.
Universal Health-Care Will this Policy Benefit the United States? By Matthew Lokant.
Health financing models. NHS Systems Strengths –Pools risks for whole population –Relies on many different revenue sources –Single centralized governance.
Impact of Hospital Provider Payment Mechanism on Household Health Service Utilization in Vietnam (preliminary results) Sarah Bales Public Policy in Asia,
Georgian Health Care 2020 Washington DC, February 1-2, 2010
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
HEALTH CARE REFORM: MANAGEMENT ACADEMY South Carolina Hospital Association Columbia, SC May 15, 2013 James Bentley, Ph.D. Silver Spring, Maryland.
Stay Well Afford Care Secure Coverage. Our Broken Health Care System 6.5 Million Uninsured 20% of Population Source: California Health Interview Survey,
PNHP Plan Principles Access to comprehensive health care is a human right The right to chose and change one’s physician is fundamental Pursuit of corporate.
The Czech Health System – its Presence and Future Pavel Hroboň L.Dittrich.
P4P and China’s Health Care Reform: Current State, Opportunities and Challenges Winnie Yip Reader in Health Policy and Economics University of Oxford “Incentives.
Health Finance Reforms in Southern Europe: Lessons from Croatia European Health Forum September 27, 2002 Akiko Maeda, Lead Health Specialist The World.
Cambodia1. 2 Cambodia Assessment Ung Phirun Chroeng Sokhan.
EXPERIENCES IN SOUTH AFRICA WITH THE INTRODUCTION OF PHARMACEUTICAL PRICING LEGISLATION Zokufa HZ, Pillay T Pharmaceutical Policy and Planning, Department.
Stay Well Afford Care Secure Coverage. Our Broken Health Care System 6.5 Million Uninsured 20% of Population Source: California Health Interview Survey,
Key issues in health care financing Di McIntyre. Objectives Introduce some key concepts Introduce a useful analytic framework Illustrate the analytic.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
A L ESSON IN H EALTH E CONOMICS C HAPTER 13 Code Blue Health Science Edition 4.
Re-thinking a roadmap to pursue Universal Health Coverage in Palestine – a discourse Awad MATARIA, PhD Health Economist World Health Organization – Eastern-Mediterranean.
Medicine Prices, Availability, Affordability and Price Components in Kazakhstan, Kyrgystan, Tajikistan & Uzbekistan Margaret Ewen Health Action International.
25 Years of Essential Medicines … progress … unfinished agenda … promising developments Jonathan D. Quick, MD, MPH, Director Essential Drugs and Medicines.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Social Health Insurance Policy Development. Presentation Policy process to date Constitutional mandate Policy context WHO Ranking Key objectives Future.
Objective The aim was to assess purchasing pharmaceuticals in the public health sector in Jordan through the joint procurement for participating parties.
Owen Smith – World Bank Washington DC – February 1 st, 2011 Health care financing in Georgia.
1 Health insurance system in Mongolia Ch. Oyun, MD, MPH.
Designing and Managing Medicines Benefits – Goals, Policy Options, Ethical Considerations Anita Katharina Wagner Department of Population Medicine Harvard.
Zokufa HZ, Pillay T Pharmaceutical Policy and Planning National Department of Health- South Africa.
Drug Policy Experience of Visegrad Group countries, Warszava Oct 29-30, 2007 Monitoring of doctor´s prescription in the Czech Republic Tomas Sechser Daniela.
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
Farid Abolhassani Social Health Insurance 15. Learning Objectives After working through this chapter, you will be able to: Define the principles of social.
Private Health Insurance
More Security and Stability If You Have Health Insurance, the Obama Plan: Ends discrimination against people with pre-existing conditions. Limits premium.
Farid Abolhassani The Changing World of Health Care Finance 13.
22 CHAPTER PUBLIC SECTOR ECONOMICS: The Role of Government in the American Economy Randall Holcombe Health Care.
Overview of China’s health care reform Wen Chen, Ph.D., Professor Fudan School of Public Health March 21, 2016.
Pharmacy Benefit Management (PBM) 101
1 Asian experiences of the extension of social security coverage - focus on health care 15 October 2007 Bangkok Hiroshi Yamabana Social Security Specialist.
Health Care in Australia Medicare and Private Health Insurance.
Health System Financing 1 |1 | Designing Health Financing System to Achieve Universal Coverage Ke Xu Health Systems Financing World Health Organization.
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
THE NEW YORK HEALTH ACT: Single Payer Health Care for New York State May 2016.
Economics of Pharmaceutical Regulation in the Mediterranean: the case of Spain and Italy Joan Costa Font LSE.
Universal Health Coverage
The Czech Health System – its Presence and Future
The Republic of Sudan: Health Financing Options
Pricing and Reimbursement Systems and Mechanisms in Greece
Spending Review Healthcare
Presentation transcript:

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Matthew Jowett, PhD Senior Health Financing Specialist Dept. Health Systems Governance & Financing WHO Geneva 29 th October 2013 Health financing policy, medicines and universal health coverage TBS Seminar on Essential Medicines and Health Products

Geneva, 29 October 2013 Universal health coverage goalsThree dimensions interlinkedEvidence from European RegionInstruments in support of UHC

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Universal health coverage goals Equity in service use (reduce gap between need and utilization) Quality of services (sufficient to improve health) Financial protection (no-one becomes poor as a result of paying for care)

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October dimensions of health care coverage Equity in service use Quality

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Moldova 2007 Population enrolment in national health insurance scheme

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 XXXXXXXX

- Formal sector workers (salaried) - Civil servants and private sector - Mandatory contributions (payroll tax) -Informal sector / non-wage -Below the official poverty line -Fully subsidized insurance contributions shared between local and national government -Informal sector / non-salaried -Above the official poverty line -Voluntary contributions with no subsidy

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October Financial coverage dimension

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Insurance effect? Moldova…..

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Georgia - outpatient medicines drives OOPs

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 More (public) money for health Public spending crowds displaces out-of-pocket payments

More health for the money…… Ref: World Health Report 2010, Chapter 4 Medicines: under-use of generics and higher than necessary prices Medicines: use of sub-standard and counterfeit medicines Medicines: in appropriate and ineffective use Services: inappropriate hospital size (low use of infrastructure) Services: medical errors and sub- optimal quality of care Services: inappropriate hospital admissions and length of stay Services & products: oversupply and overuse of equipment, investigations and procedures Health workers: inappropriate or costly staff mix, unmotivated workers Interventions: inefficient mix / inappropriate level of strategies Leakages: waste, corruption, fraud

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Estimated average (median) retail mark-ups: Georgia and selected EU countries EU price source: OBIG/PPRI

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Affordability of standard treatments as % of minimum subsistence allowance

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Portugal - May 2011 Set the maximum price of the first generic introduced in the market to 60% of the branded product with similar active substance; revise reference-pricing system based on international prices Pricing and reimbursement of pharmaceuticals Electronic prescription for medicines & diagnostic covered by public reimbursement compulsory for physicians in public and private sector; improve monitoring system of prescription and set in place a systematic assessment by individual doctor in terms of volume and value; induce physicians at all levels of the system, public & private, to prescribe generic medicines & the less costly available branded product; establish clear rules for the prescription & complementary diagnostic exams (prescription guidelines for physicians); remove entry barriers for generic medicines. Prescription and monitoring prescription Change the calculation of profit margin into a regressive mark-up and a flat fee for wholesale companies and pharmacies; ensures a reduction in public spending and encourage the sales of less expensive pharmaceuticals; lower profits will contribute at least 50M€ to the reduction in public expense with drugs distribution. If this does not produce the expected savings in the distribution profits, introduce a pay-back scheme. Pharmacies sector Set up centralized procurement system for purchase of medical goods, to reduce costs and waste; finalize coding system and common registry for medical supplies; take measures to increase competition among private providers and reduce by at least 10% overall NHS spending with private providers delivering diagnostic and therapeutical services by end 2011 and by an additional 10% by end 2012; introduce regular revision of fee s paid to private providers to reduce cost of more mature diagnostic & therapeutical services; assess compliance with European competition rules. Centralized purchasing and procurement

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Some instruments to support UHC Spend on cost- effective public health interventions Better mix, distribution, capacity of HRH Targeted incentives to those using & delivering priority services Ensure health financing as “pooled” as possible

TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013